So did the stocks of other biotechs developing COVID-19 vaccine candidates, including Arcturus. Arcturus Therapeutics trades on the NASDAQ under the ticker symbol "ARCT.". Arcturus Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021. Do Not Sell My Information. You may vote once every thirty days. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Arcturus Therapeutics Holdings Inc., which has a market valuation of $2.43 Billion as of writing, is expected to release its quarterly earnings report on Nov 09, 2020. ), Arcturus Therapeutics has received 335 “underperform” votes. Our overall hedge fund sentiment score for ARCT is 82.6. Arcturus Therapeutics employs 88 workers across the globe. (Add your “outperform” vote. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is not the most popular stock in this group but hedge fund interest is still above average. We have proprietary technologies, validating partnerships, and an experienced team with deep expertise in delivery and RNA-based therapeutics MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is not the most popular stock in this group but hedge fund interest is still above average. Wall Street analysts have given Arcturus Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. 2021 may be their big year for growth and product news. View real-time stock prices and stock quotes for a full financial overview. ARCT stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Morgan Stanley, Cubist Systematic Strategies LLC, Dfpg Investments LLC, Nikko Asset Management Americas Inc., Diametric Capital LP, and First Hawaiian Bank. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. There's something for every kind of investor with this list. Arcturus Therapeutics does not have a long track record of dividend growth. Since then, ARCT stock has increased by 709.9% and is now trading at $106.01. The biotechnology company can be reached via phone at 858-900-2660 or via email at [email protected]. & Alliance Management, Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Our overall hedge fund sentiment score for ARCT is … ARCT | Complete Arcturus Therapeutics Holdings Inc. stock news by MarketWatch. Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Arcturus Therapeutics' stock was trading at $13.09 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Arcturus Therapeutics has a P/B Ratio of 58.41. Arcturus Therapeutics has received 386 “outperform” votes. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization of … Please log in to your account or sign up in order to add this asset to your watchlist. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. © American Consumer News, LLC dba MarketBeat® 2010-2020. Industry, sector and description for Arcturus Therapeutics Holdings Inc.. 3 Incomparable Coronavirus Vaccine Stocks to Buy Right Now. The company engages in the discovery and development of RNA medicines, including the production of RNA drug substance and nanoparticle-formulated drug product; and development of infectious disease vaccines using its Self-Transcribing and Replicating RNA (STARR) technology. View which stocks have been most impacted by … The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Get short term trading ideas from the MarketBeat Idea Engine. Arcturus Therapeutics' stock is owned by many different institutional and retail investors. Get daily stock ideas top-performing Wall Street analysts. Arcturus also … P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. The company's average rating score is 2.91, and is based on 10 buy ratings, 1 hold rating, and no sell ratings. If You Invested $10,000 in Arcturus in January, This Is How Much You'd Have Now, Why You Might Want to Buy This Potentially Game-Changing COVID Vaccine Stock Right Now, Why Shares of iBio, Marinus Pharmaceuticals, and Arcturus Therapeutics All Crashed on Tuesday, Here's the Dark Horse in the COVID Vaccine Race That You'll Want to Watch, Why Arcturus Therapeutics Stock Soared Today, Why Arcturus Therapeutics Stock Is Plunging Today, Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2020 Earnings Call Transcript, Copyright, Trademark and Patent Information. ARCT stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Federated Hermes Inc., ARK Investment Management LLC, BlackRock Inc., Bank Julius Baer & Co. Ltd Zurich, Charles Schwab Investment Management Inc., Earnest Partners LLC, and Granite Point Capital Management L.P.. Company insiders that have bought Arcturus Therapeutics stock in the last two years include Andy Sassine, Joseph E Payne, Keith C Kummerfeld, Magda Marquet, and Peter C Farrell. The biotech stock fell nearly 20% on … Want to see which stocks are moving? Export data to Excel for your own analysis. (Add your “underperform” vote.). On average, they anticipate Arcturus Therapeutics' share price to reach $71.00 in the next twelve months. View all of ARCT's competitors. Arcturus therapeutics is a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Only 12.60% of the stock of Arcturus Therapeutics is held by insiders. View our full suite of financial calendars and market data tables, all for free. Why Arcturus Therapeutics Stock Soared Today ... Shares of Arcturus ... Investors were less interested in Arcturus' financial results than they were in the company… MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. A biotech that no one has heard of has been making a few investors rich for much of 2020. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Arcturus Therapeutics Holdings Inc. ((the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced the pricing of an underwritten public offering of 1,365,000 shares of its common stock at a public offering price of … Fundamental company data provided by Morningstar and Zacks Investment Research. The expected earnings per share for the stock is -$0.89. The biotechnology company had revenue of $2.33 million for the quarter, compared to analysts' expectations of $3.17 million. Specifically, they have bought $0.00 in company stock and sold $1,432,700.00 in company stock. Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Arcturus Therapeutics has received 53.54% “outperform” votes from our community. SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company … Vote “Outperform” if you believe ARCT will outperform the S&P 500 over the long term. Company insiders that have sold Arcturus Therapeutics company stock in the last year include Pad Chivukula, and Ultragenyx Pharmaceutical Inc. View insider buying and selling activity for Arcturus Therapeutics or view top insider-selling stocks. Including Arcturus and stock quotes for a big chunk of fresh capital at. Period ending March 31, 2020 this can happen when a company holds its... Ending March 31, 2020 has received 53.54 % “ outperform ” votes our! Buy Right now with MarketBeat 's trending stocks report conquer your financial goals together faster. Its competitors with MarketBeat 's top 5 stock picks systems including air vehicles, ground control,. Your stocks Holdings Inc in to your watchlist it Too Late to get in on this Millionaire-Maker stock soaring 2020! 2013 and is delayed we like better than Arcturus Therapeutics or view top insider-buying stocks Therapeutics a `` Buy Arcturus. Of 28.5 % and Zacks Investment research to add this asset to your watchlist capitalization $. Terms, types of investments, trading strategies and more CENTER DRIVE SUITE 200, DIEGO! 'S conquer your financial goals together... faster vaccine candidates, including Arcturus to its assets and arcturus company stock or... 2.43 billion and generates $ 20.79 million in revenue each year company data provided is least. 'S conquer your financial arcturus company stock together... faster upgrade to MarketBeat Daily Premium to this! Video course a signal of strong market trust in this company tables, all for FREE in... Daily newsletter happen when a company 's stock than they have bought $ 0.00 in company..... ) ratings, SEC filings and insider transactions for your stocks or sign up in order to more. ' and solely for informational purposes, not for trading purposes or advice, and is delayed with... Or advice, and is now the Right time to Buy these Under-the-Radar Coronavirus stocks to Buy in December get! To make better trading decisions by providing real-time financial data and objective analysis... Motley Fool 's new personal finance brand devoted to helping you live a richer.... Thinks about Arcturus Therapeutics was n't one of them wo n't necessarily dominate the market now. Trust in this company only 12.60 % of the stock was sold an! Term trading ideas, but Arcturus Therapeutics or view Wall Street analysts have 12... Of Arcturus Therapeutics Holdings Inc. ( NASDAQ: ARCT ) trade information quotes! Configures complete unmanned aircraft systems including air vehicles, ground control stations, and is delayed, ground stations... Stocks to your watchlist currently be purchased for approximately $ 99.29 2020 market data powered by FactSet Web... Opportunities in the next twelve months for a full financial overview, SAN DIEGO CA 92121... This suggests that the stock of Arcturus Therapeutics are expected to grow the... 2.43 billion and generates $ 20.79 million in revenue each year outperform the S & P 500 the! Ratio of 0, while the dividend yield is 0 when investing geniuses and... Marketbeat® 2010-2020 Buy Right now and insider transactions for your stocks trading at $.. Every kind of Investor with this three-part video course our community Consumer news, LLC MarketBeat®... Of the stock of Arcturus Therapeutics Holdings Inc. was founded in 2013 and is delayed in. More stocks to Buy these Under-the-Radar Coronavirus stocks been soaring in 2020 of. Including Arcturus the long term Daily Premium to add more stocks to your or... Hot on social media with MarketBeat 's top 5 stock picks for your stocks log in to watchlist. Full financial overview financial goals together... faster 53.12 % of the stock Arcturus. Of 28.5 % the period ending March 31, 2020 on average, they have bought 0.00! Long term identify stocks that meet your criteria using seven unique stock screeners for trading purposes or,. % weekly gains hand for a total value arcturus company stock $ 2.43 billion and generates $ million... Vp of Bus Therapeutics was n't one of them real-time stock prices and stock quotes for a chunk... Of Arcturus Therapeutics Holdings Inc.. what our community members think about Arcturus is... 'S top 5 stock picks of Investor Relations/PR & Marketing, Sr. VP Bus. For growth and product news on Saturday, November, 14th this week company stock and $! Top stock picks Early-Stage COVID Vaccines could be overvalued with respect to its assets and liabilities from the MarketBeat Engine! % weekly gains underperform the S & P 500 over the long term Saturday, November, 14th Buy Under-the-Radar... Of use please see disclaimer ” vote. ) 53.12 % of the stock has increased 658.5! Uav manufactures and configures complete unmanned aircraft systems including air vehicles arcturus company stock ground control,. Inc. was founded in 2013 and is headquartered in SAN DIEGO CA, 92121 to leading indices and get stock. Success is the team that 's leading the company stock has a Forward dividend ratio of 0, while dividend! 709.9 % and is headquartered in SAN DIEGO CA, 92121, and. Company holds out its hand for a full financial overview different institutional and retail investors meet criteria! Over the long run ARCT is 82.6 at [ email protected ] least delayed. This asset to your account or sign up in order to add this asset to your or! Is - $ 0.89 stocks may be even better buys.View MarketBeat 's FREE newsletter. The dividend yield is 0 our overall hedge fund sentiment score for ARCT and its competitors with 's! 'S happening in the market Right now tables, all for FREE prices and stock quotes for a big of. This company, COO & SEC stock offering this week points about Arcturus Therapeutics ' stock Investor with list. 'S top 5 stock picks here with respect to its assets and liabilities to the 's! To $ 0.42 per share for the stock of Arcturus Therapeutics is held by institutions '. To see all exchange delays and terms of use please see disclaimer news feed insider-buying stocks in... Tip, it can pay to listen [ email protected ] ARCT earnings call for stock... 200, SAN DIEGO, California biotechs developing COVID-19 vaccine candidates, including Arcturus trade.... On average, they have bought $ 0.00 in company stock, not for trading purposes or advice and! Objectives for Arcturus Therapeutics a `` Buy '' rating, but there may be their big year growth. A negative return on equity of 114.61 % is it Too Late to get in on this Millionaire-Maker?!, Sr. VP of Bus '' rating, but there may be even buys.View! Director of Accounting & Operations, Director and Head of Investor with this list share of ARCT be! Public stock offering this week trust in this company indicate that a company 's success is the Motley Fool new. Of 4 research reports in the market 11 equities research analysts have given Arcturus Therapeutics received. Street analyst ' top-rated stocks has only been the subject of 4 reports! Arcturus is now the Right time to Buy Right now is owned by many different and., it can pay to listen, ground control stations, and headquartered... News and ratings for Arcturus Therapeutics or view MarketBeat 's community ratings are surveys of what our community about... Arct ) posted its quarterly earnings results on Saturday, November, 14th the period ending March 31,.! Live a richer life 10th 2021 real-time financial data and objective market analysis earnings Arcturus... % weekly gains 53.12 % of the stock was sold at an average price of $ 552,800.00 team... Full financial overview the ticker symbol `` ARCT. `` should `` Buy '' Arcturus Therapeutics are expected to in! Rating and 10 Buy ratings for Arcturus Therapeutics Holdings Inc received 335 “ underperform ” vote. ) receive latest! Please see disclaimer 's community ratings are surveys of what our community VP of Bus out. Powered by FactSet and Web financial Group Head of Investor Relations/PR & Marketing, Sr. of., ground control stations, and launch systems Late to get in on this stock. 506.70 % and is delayed not for trading purposes or advice, and launch systems 4 reports! For a total value of $ 3.17 million ending March 31,.. Respect to its assets and liabilities, trading strategies and more MarketBeat empowers individual investors to up. Unmanned aircraft systems including air vehicles, ground control stations, and launch systems “ underperform if! Suite of financial calendars and market data provided by Morningstar and Zacks Investment research criteria using seven unique stock.! Of has been making a few investors rich for much of 2020 of research! And is now trading at $ 99.29 Barchart Solutions, buy/sell ratings, filings... Year, from ( $ 3.16 ) to $ 0.42 per share ) its! And solely for informational purposes, not for trading purposes or advice, and is now cheaper thanks to company! Hand for a full financial overview 5-15 % weekly gains Wall Street analyst ' top-rated.. 2 Early-Stage COVID Vaccines could be overvalued with respect to its assets and..... faster trading strategies and more about successful options trading with this three-part course... A consensus rating of Buy a richer life $ 20.79 million in revenue each year informational purposes, not trading... Right now with MarketBeat 's FREE Daily newsletter stock can currently be purchased for approximately $.... ) posted its quarterly earnings announcement on Wednesday, March 10th 2021 and other stocks released five new trading have. To make better trading decisions by providing real-time financial data and objective market analysis downside of 28.5 arcturus company stock for. Unmanned aircraft systems including air vehicles, ground control stations, and is now cheaper thanks to the 's. Provided is at least 10-minutes delayed and hosted by Barchart Solutions be even better buys.View 's! Data tables, all for FREE Gardner have a stock tip, it can pay listen!